共 112 条
[1]
Russnes HG(2017)Breast cancer molecular stratification: from intrinsic subtypes to integrative clusters Am J Pathol 187 2152-2162
[2]
Lingjaerde OC(2014)Estrogen and progesterone receptors in breast cancer Future Oncol 10 2293-2301
[3]
Borresen-Dale AL(2014)US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status J Natl Cancer Inst 106 dju055-720
[4]
Caldas C(2014)Current status of hormone therapy in patients with hormone receptor positive (HR+) advanced breast cancer Breast 23 710-49S
[5]
Yip CH(2015)Advances in targeted therapy for breast cancer Fed Pract 32 46S-530
[6]
Rhodes A(2020)Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study Lancet Oncol 21 519-579
[7]
Howlader N(2017)Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2- metastatic breast cancer: a focus on ribociclib Breast Cancer (Dove Med Press) 9 567-6
[8]
Altekruse SF(2003)Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 643-1468
[9]
Li CI(2014)Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes Breast Cancer Res 16 475-3427
[10]
Chen VW(2016)Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer J Clin Oncol 34 1460-1366